Erica L. Vieira

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Corrigendum to "Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms" [EBioMedicine (2026) Jul 10: 106339].

Corrigendum to "Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms" [EBioMedicine (2026) Jul 10: 106339].

Journal: EBioMedicine

Published: September 05, 2026

Peripheral GABAergic markers in late-life depression: Links to clinical outcomes.

Peripheral GABAergic markers in late-life depression: Links to clinical outcomes.

Journal: Brain research

Published: February 15, 2026

Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.

Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.

Journal: EBioMedicine

Published: November 24, 2025

Assessment of noninvasive quantification of [18F]SynVesT-1 with simplified reference tissue model 2 in an adolescent and youth cohort.

Assessment of noninvasive quantification of [18F]SynVesT-1 with simplified reference tissue model 2 in an adolescent and youth cohort.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 08, 2025

Reduced circulating progenitor cells in older adults with major depression: Evidence of accelerated biological aging.

Reduced circulating progenitor cells in older adults with major depression: Evidence of accelerated biological aging.

Journal: Brain, behavior, & immunity - health

Published: August 03, 2025

Decreased Mitochondrial DNA Integrity and Elevated Inflammatory Markers in Late-Life Depression: A Longitudinal Study.

Decreased Mitochondrial DNA Integrity and Elevated Inflammatory Markers in Late-Life Depression: A Longitudinal Study.

Journal: Biological psychiatry global open science

Published: April 18, 2025

Astrogliosis Marker [11C]SL25.1188 After COVID-19 With Ongoing Depressive and Cognitive Symptoms.

Astrogliosis Marker [11C]SL25.1188 After COVID-19 With Ongoing Depressive and Cognitive Symptoms.

Journal: Biological psychiatry

Published: April 30, 2024

Exosome-associated mitochondrial DNA in late-life depression: Implications for cognitive decline in older adults.

Exosome-associated mitochondrial DNA in late-life depression: Implications for cognitive decline in older adults.

Journal: Journal of affective disorders

Published: March 22, 2024

Sex differences in plasma proteomic markers in late-life depression.

Sex differences in plasma proteomic markers in late-life depression.

Journal: Psychiatry research

Published: July 30, 2023

Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms.

Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms.

Journal: JAMA psychiatry

Published: May 31, 2023

Major depression, physical health and molecular senescence markers abnormalities.

Major depression, physical health and molecular senescence markers abnormalities.

Journal: Nature. Mental health

Published: March 01, 2023

Astrogliosis marker 11C-SL25.1188 PET in traumatic brain injury with persistent symptoms.

Astrogliosis marker 11C-SL25.1188 PET in traumatic brain injury with persistent symptoms.

Journal: Brain : a journal of neurology

Published: October 14, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026